European Society of Endocrinology Journal Impact Factors Announced

Thomson Reuters has revealed this year's Impact Factors for four European Society of Endocrinology publications. Impact factors are a metric that reflect the frequency that peer-reviewed journals are cited by researchers, making them an important tool for evaluating a journal’s quality.

The European Journal of Endocrinology's Impact Factor has risen from 3.136 to 3.686 in 2013, the second highest in its history, reinforcing its standing as a leading journal in the field of clinical endocrinology and metabolism. We are delighted with this result and would like to thank the world-class editors, authors and reviewers who make the journal such a success.

The Journal of Molecular Endocrinology continues to improve in strength with an increased 2013 Impact Factor of 3.621.  The Editorial Board’s strict acceptance policy and impressive commissioning strategy continues to ensure that JME is a leading journal in basic endocrinology.

Endocrine-Related Cancer received a strong 2013 impact factor of 4.907 and remains in the top quartile in both its categories: oncology and endocrinology & metabolism, reinforcing its standing as the leading journal linking oncology and endocrinology. ERC’s underlying five-year impact factor, providing a longer-term measure of the journal’s quality, is 5.237.

The Journal of Endocrinology has received a 2013 impact factor of 3.586; the second highest it has ever received. Its five-year impact factor of 3.743, its highest ever, reflects the high-quality research and reviews published. The current editorial and marketing strategies should stand JOE in good stead to build on this in future years.

All ESE members receive free online access to the official ESE journals.